Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease

Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor Stafford, Julie Joubert, Tarek Antar, Alejandro Carrasco-Martinez, Mary B. Makarious, Bradford Casey, Dan Vitale, Kristin Levine, Hampton Leonard, Claire E. Wegel, Justin Solle, Mike A. Nalls, Cornelis Blauwendraat, Andrew B. Singleton, Manuela M. X. Tan, Hirotaka Iwaki, Huw R. Morris, the Global Parkinson’s Genetics Program (GP2)
doi: https://doi.org/10.1101/2022.11.25.22282764

Article Information

doi 
https://doi.org/10.1101/2022.11.25.22282764
History 
  • December 13, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Clodagh Towns1,
  2. Madeleine Richer1,
  3. Simona Jasaityte1,
  4. Eleanor Stafford1,
  5. Julie Joubert1,
  6. Tarek Antar2,
  7. Alejandro Carrasco-Martinez1,
  8. Mary B. Makarious1,5,
  9. Bradford Casey8,
  10. Dan Vitale3,4,
  11. Kristin Levine3,4,
  12. Hampton Leonard3,4,5,
  13. Claire E. Wegel7,
  14. Justin Solle8,
  15. Mike A. Nalls2,3,4,
  16. Cornelis Blauwendraat2,4,
  17. Andrew B. Singleton2,4,
  18. Manuela M. X. Tan6,
  19. Hirotaka Iwaki2,3,4,
  20. Huw R. Morris1,*,
  21. the Global Parkinson’s Genetics Program (GP2)
  1. 1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK
  2. 2Integrative Genomics Unit, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
  3. 3Data Tecnica International, Washington, DC, USA
  4. 4Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
  5. 5Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
  6. 6Department of Neurology, Oslo University Hospital, Oslo, Norway
  7. 7Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN, USA
  8. 8Department of Clinical Research, Michael J. Fox Foundation for Parkinson’s Research, New York City, NY, USA
  1. ↵*Corresponding author: Professor Huw R Morris, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, h.morris{at}ucl.ac.uk.
Back to top
Posted December 13, 2022.
Download PDF

Supplementary Material

Email
Global Parkinson’s Genetics Program (GP2) Complex Network Protocol: Defining the causes of sporadic Parkinson’s disease
Clodagh Towns, Madeleine Richer, Simona Jasaityte, Eleanor Stafford, Julie Joubert, Tarek Antar, Alejandro Carrasco-Martinez, Mary B. Makarious, Bradford Casey, Dan Vitale, Kristin Levine, Hampton Leonard, Claire E. Wegel, Justin Solle, Mike A. Nalls, Cornelis Blauwendraat, Andrew B. Singleton, Manuela M. X. Tan, Hirotaka Iwaki, Huw R. Morris, the Global Parkinson’s Genetics Program (GP2)
medRxiv 2022.11.25.22282764; doi: https://doi.org/10.1101/2022.11.25.22282764
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area